Carboplatin Pfizer

Carboplatin Pfizer Drug Interactions





Zuellig Pharma


Full Prescribing Info
Drug Interactions
The combination of carboplatin therapy and other myelosuppressive agents may warrant dosage adjustments in order to avoid cumulative toxic effects. Due to the possibility of impairment in renal function, it is recommended that carboplatin therapy be avoided in patients receiving amino-glycoside antibiotics or other nephrotoxic drugs.
An increased incidence of emesis has been reported when carboplatin and other emetogenic drugs are given concurrently or carboplatin is administered to patients who previously received emetogenic therapy.
Vaccination with a live vaccine should be avoided in patients receiving carboplatin.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in